Skip to Main Content
Skip Nav Destination






(e KAL lan tide)

Brand Names: US

  • Kalbitor

Therapeutic Category

  • Kallikrein Inhibitor

Generic Availability (US)


Index Terms

  • DX-88

Clinical Pharmacology

Mechanism of Action

Ecallantide is a recombinant protein which inhibits the conversion of high molecular weight kininogen to bradykinin by selectively and reversibly inhibiting plasma kallikrein. Unregulated bradykinin production is thought to contribute to the increased vascular permeability and angioedema observed in HAE.

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal